MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 198 filers reported holding MEDICINES CO in Q3 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $51,509,000 | +71.2% | 606,414 | +0.8% | 0.04% | +59.3% |
| Q3 2019 | $30,083,000 | +43.0% | 601,652 | +4.3% | 0.03% | +42.1% |
| Q2 2019 | $21,043,000 | +39.5% | 576,986 | +6.9% | 0.02% | +35.7% |
| Q1 2019 | $15,080,000 | +44.7% | 539,547 | -0.9% | 0.01% | +27.3% |
| Q4 2018 | $10,418,000 | -36.8% | 544,283 | -1.3% | 0.01% | -26.7% |
| Q3 2018 | $16,493,000 | -14.1% | 551,423 | +5.4% | 0.02% | -16.7% |
| Q2 2018 | $19,198,000 | +13.3% | 523,113 | +1.7% | 0.02% | +12.5% |
| Q1 2018 | $16,950,000 | +24.0% | 514,595 | +2.9% | 0.02% | +23.1% |
| Q4 2017 | $13,670,000 | -25.0% | 499,984 | +1.6% | 0.01% | -27.8% |
| Q3 2017 | $18,232,000 | -14.4% | 492,240 | -12.2% | 0.02% | -14.3% |
| Q2 2017 | $21,305,000 | -21.4% | 560,521 | +1.2% | 0.02% | -36.4% |
| Q1 2017 | $27,097,000 | +53.0% | 554,133 | +6.2% | 0.03% | +50.0% |
| Q4 2016 | $17,711,000 | -8.8% | 521,832 | +1.4% | 0.02% | -15.4% |
| Q3 2016 | $19,424,000 | +15.8% | 514,686 | +3.2% | 0.03% | +13.0% |
| Q2 2016 | $16,775,000 | +8.8% | 498,819 | +2.8% | 0.02% | +4.5% |
| Q1 2016 | $15,415,000 | -11.9% | 485,198 | +3.5% | 0.02% | -15.4% |
| Q4 2015 | $17,507,000 | +6.7% | 468,857 | +8.5% | 0.03% | 0.0% |
| Q3 2015 | $16,403,000 | +38.0% | 432,096 | +4.0% | 0.03% | +44.4% |
| Q2 2015 | $11,886,000 | +1.5% | 415,435 | -0.6% | 0.02% | +5.9% |
| Q1 2015 | $11,715,000 | +3.6% | 418,102 | +2.3% | 0.02% | -5.6% |
| Q4 2014 | $11,308,000 | +24.7% | 408,654 | +0.6% | 0.02% | +20.0% |
| Q3 2014 | $9,071,000 | -24.1% | 406,414 | -1.1% | 0.02% | -25.0% |
| Q2 2014 | $11,945,000 | +2.1% | 411,047 | -0.2% | 0.02% | -4.8% |
| Q1 2014 | $11,704,000 | -48.9% | 411,806 | -30.5% | 0.02% | -51.2% |
| Q4 2013 | $22,895,000 | +21.8% | 592,834 | +5.7% | 0.04% | +10.3% |
| Q3 2013 | $18,794,000 | +22.1% | 560,669 | +12.1% | 0.04% | +14.7% |
| Q2 2013 | $15,391,000 | – | 500,366 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |